45 structural-engineering-"https:" "https:" "https:" "https:" "https:" "https:" "https:" "Dip" positions at City of Hope
Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
. Experience with AI/ML algorithms and prediction model development. Familiarity with data structures, algorithms, software engineering best practices, and computational efficiency is highly desirable
-
clinical setting Your qualifications should include: · Ph.D. degree chemistry, biochemistry, structural biology, biophysics or a related discipline is required. · Knowledge of protein engineering
-
cancer. Work in the lab utilizes both genetically engineered mouse models and in vitro systems. A combination of state-of-the-art surgical, genetic, cellular, biochemical, imaging, and metabolic flux
-
I position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages advanced multi-omic technologies, coupled with experimental perturbations and
-
, shaping the future of medicine through cutting-edge research. A Postdoctoral Fellowship position is available in the RSP Lab led by Dr. Sklavenitis Pistofidis. The RSP Lab (https://rsplab.org ) leverages
-
Join the Pediatric Immunotherapy Research Lab (PI: Leo Wang) in the Beckman Research Institute of City of Hope , where we use cutting-edge techniques to understand and engineer potent immune
-
. Gu’s lab and research, please visit: https://gu-lab.net and https://www.cityofhope.org/Zhaohui-Gu As a successful candidate, you will: Design and execute experiments to understand the molecular
-
Medicine, and member of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug
-
-life environmental exposures and the prenatal origins of childhood leukemia, for example in our ReCord Study (https://record.umn.edu ). Applicants are required to submit a CV accompanied by a cover
-
to immunotherapies for type 1 diabetes as well as somatic variants in the pancreas and immune cells of organ donors with type 1 diabetes. For more information on the Shapiro Laboratory please visit here: https